Alcohol addiction, gut microbiota, and alcoholism treatment: a review
Alcohol addiction is a leading risk factor for personal death and disability. In 2016, alcohol
use caused 2.2% of female deaths and 6.8% of male deaths, and disability-adjusted life …
use caused 2.2% of female deaths and 6.8% of male deaths, and disability-adjusted life …
Alcohol and opioid use, co‐use, and chronic pain in the context of the opioid epidemic: A critical review
K Witkiewitz, KE Vowles - Alcoholism: clinical and experimental …, 2018 - Wiley Online Library
The dramatic increase in opioid misuse, opioid use disorder (OUD), and opioid‐related
overdose deaths in the United States has led to public outcry, policy statements, and funding …
overdose deaths in the United States has led to public outcry, policy statements, and funding …
Prevention, screening, and treatment for heavy drinking and alcohol use disorder
J Knox, DS Hasin, FRR Larson, HR Kranzler - The Lancet Psychiatry, 2019 - thelancet.com
Heavy drinking and alcohol use disorder are major public health problems. Practitioners not
specialising in alcohol treatment are often unaware of the guidelines for preventing …
specialising in alcohol treatment are often unaware of the guidelines for preventing …
A potential role for the gut microbiome in substance use disorders
Pathological substance use disorders represent a major public health crisis with limited
effective treatment options. While much work has been done to understand the neuronal …
effective treatment options. While much work has been done to understand the neuronal …
Alcohol use disorder: neurobiology and therapeutics
W Yang, R Singla, O Maheshwari, CJ Fontaine… - Biomedicines, 2022 - mdpi.com
Alcohol use disorder (AUD) encompasses the dysregulation of multiple brain circuits
involved in executive function leading to excessive consumption of alcohol, despite negative …
involved in executive function leading to excessive consumption of alcohol, despite negative …
Role of cannabidiol in the therapeutic intervention for substance use disorders
F Navarrete, MS García-Gutiérrez… - Frontiers in …, 2021 - frontiersin.org
Drug treatments available for the management of substance use disorders (SUD) present
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …
Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules
P Berríos-Cárcamo, M Quezada, ME Quintanilla… - Antioxidants, 2020 - mdpi.com
Drug abuse is a major global health and economic problem. However, there are no
pharmacological treatments to effectively reduce the compulsive use of most drugs of abuse …
pharmacological treatments to effectively reduce the compulsive use of most drugs of abuse …
Evidence-based pharmacotherapies for alcohol use disorder: clinical pearls
J Fairbanks, A Umbreit, BP Kolla, VM Karpyak… - Mayo Clinic …, 2020 - Elsevier
Pathologic alcohol use affects more than 2 billion people and accounts for nearly 6% of all
deaths worldwide. There are three medications approved for the treatment of alcohol use …
deaths worldwide. There are three medications approved for the treatment of alcohol use …
Neuroimmune mechanisms of psychostimulant and opioid use disorders
Substance use disorders are global health problems with few effective treatment options.
Unfortunately, most potential pharmacological treatments are hindered by abuse potential of …
Unfortunately, most potential pharmacological treatments are hindered by abuse potential of …
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - frontiersin.org
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …